Confident Investing Starts With TipRanks Premium

Get 55% Off
TipRanks
Go Ultimate55% OFF

Bioextrax AB (BIOEX) Stock Price & Analysis

BIOEX Stock Chart & Stats

SEK 2.34SEK 0.02(0.86%)
At close: 5:30 PM GMT+1
SEK 2SEK 2.25SEK 2.53 Aug17 Aug31 Aug14 Sep28 Sep12 Oct26 Oct
Day’s Range
SEK 2.21 - SEK 2.35
52-Week Range
SEK 1.60 - SEK 3.59
Previous Close
SEK 2.32
Volume
15.49K
Average Volume (3M)
71.99K
Market Cap
SEK 115.51M
Enterprise Value
SEK 109.23M
Total Cash (Recent Filing)
SEK 7.39M
Total Debt (Recent Filing)
SEK 0
Price to Earnings (P/E)
―
Beta
0.79
Next Earnings
Nov 20, 2026 (Est.)
EPS Estimate
-0.09
Next Dividend Ex-Date
N/A
Dividend Yield
N/A

Bulls Say, Bears Say

Bulls Say

Debt-Free Balance Sheet

Zero reported debt reduces refinancing and interest-rate exposure, giving Bioextrax greater financial flexibility than a similarly loss-making business with leverage. This structure can help preserve strategic options while the company works toward commercialization and more sustainable profitability.

Renewable Bioprocessing Focus

Bioextrax operates in renewable industrial biotechnology, converting biological raw materials into higher-value products. This business model is aligned with longer-term demand for resource-efficient processing and could support differentiated applications if the company successfully commercializes its technologies.

Potential Operating Leverage

The positive gross profit recorded in 2023 indicates that the business has demonstrated some ability to generate economic value above direct costs at a higher revenue level. Although not sustained, that result provides evidence of possible operating leverage if commercialization expands revenue.

Bears Say

Small And Declining Revenue

Very small and declining revenue indicates that Bioextrax has not yet established a durable commercial scale. Continued top-line weakness limits operating leverage, reduces the ability to absorb fixed costs, and makes the company more dependent on successful future commercialization efforts.

Structurally Weak Profitability

Persistent gross, operating, and net losses show that the current revenue base does not cover the company’s cost structure. Unless margins improve materially, ongoing losses can consume capital, restrict investment capacity, and delay the transition from development activity to a self-sustaining business.

Accelerating Cash Burn

Negative operating and free cash flow means Bioextrax is not funding its activities internally, while the worsening 2025 burn rate increases the need for external financing. Repeated funding requirements could dilute existing ownership or constrain development if capital becomes harder to obtain.

Bioextrax AB News

BIOEX FAQ

What was Bioextrax AB’s price range in the past 12 months?
Bioextrax AB lowest stock price was kr 1.60 and its highest was kr 3.59 in the past 12 months.
What is Bioextrax AB’s market cap?
Bioextrax AB’s market cap is kr 115.51M.
When is Bioextrax AB’s upcoming earnings report date?
Bioextrax AB’s next earnings report is estimated for Nov 20, 2026 (not yet confirmed), which is in 19 days.
How were Bioextrax AB’s earnings last quarter?
Bioextrax AB released its earnings results on Aug 21, 2026. The company reported -kr 0.1 earnings per share for the quarter, missing the consensus estimate of -kr 0.09 by -kr 0.01.
Is Bioextrax AB overvalued?
Not enough analysts have published a price target to calculate whether the price is overvalued.
Does Bioextrax AB pay dividends?
Bioextrax AB does not currently pay dividends.
What is Bioextrax AB’s EPS estimate?
Bioextrax AB’s EPS estimate is -0.09.
How many shares outstanding does Bioextrax AB have?
Bioextrax AB has 49,364,758 shares outstanding.
What happened to Bioextrax AB’s price movement after its last earnings report?
Bioextrax AB reported an EPS of -kr 0.1 in its last earnings report, missing expectations of -kr 0.09. Following the earnings report the stock price went up 0.496%.
Which hedge fund is a major shareholder of Bioextrax AB?
Currently, no hedge funds are holding shares in SE:BIOEX
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology